Cas:1107-00-2 4,4′-(hexafluoroisopropylidene)diphthalicanhydride manufacturer & supplier

We serve Chemical Name:4,4′-(hexafluoroisopropylidene)diphthalicanhydride CAS:1107-00-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4,4'-(hexafluoroisopropylidene)diphthalicanhydride

Chemical Name:4,4′-(hexafluoroisopropylidene)diphthalicanhydride
CAS.NO:1107-00-2
Synonyms:1,3-Isobenzofurandione, 5,5′-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)bis-;1,3-Isobenzofurandione, 5,5′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-;4,4′-(Hexafluoroisopropylidene)bis(phthalic anhydride);5,5′-(1,1,1,3,3,3-Hexafluoropropane-2,2-diyl)bis(2-benzofuran-1,3-dione);MFCD00039143;6f-dianhydride;5,5′-(Perfluoropropane-2,2-diyl)bis(isobenzofuran-1,3-dione);EINECS 214-170-0;5-[2-(1,3-dioxo-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-benzofuran-1,3-dione;5,5′-(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)bis(2-benzofurane-1,3-dione);4,4′-(2,2,2-Trifluoro-1-(trifluoromethyl)ethylidene)diphthalic anhydride;5,5′-(1,1,1,3,3,3-Hexafluoro-2,2-propanediyl)bis(2-benzofuran-1,3-dione);4,4′-(hexafluoroisopropylidene)diphthalicanhydride
Molecular Formula:C19H6F6O6
Molecular Weight:444.238
HS Code:2932999099

Physical and Chemical Properties:
Melting point:244-247 °C(lit.)
Boiling point:494.5±45.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.556
PSA:86.74000
Exact Mass:444.006866
LogP:3.05

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3261 8/PG 2
Packing Group:II


Contact us for information like 1,3-Isobenzofurandione, 5,5′-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)bis- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4′-(hexafluoroisopropylidene)diphthalicanhydride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-[2-(1,3-dioxo-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-benzofuran-1,3-dione Use and application,5,5′-(1,1,1,3,3,3-Hexafluoropropane-2,2-diyl)bis(2-benzofuran-1,3-dione) technical grade,usp/ep/jp grade.


Related News: The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” 4,4′-(hexafluoroisopropylidene)diphthalicanhydride manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. 4,4′-(hexafluoroisopropylidene)diphthalicanhydride supplier With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved. 4,4′-(hexafluoroisopropylidene)diphthalicanhydride vendor It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. 4,4′-(hexafluoroisopropylidene)diphthalicanhydride factory Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease.